EBRO 2017

PORTEC-1 results

RT Control

p value

Local recurrence

4% 14% <0.001

5-year survival

81% 85% 0.31

Complications

25% 6% <0.0001

RT recommended only if two adverse features present: age ≥ 60, deep myometrial invasion, G3.